Clinical trial
Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
NCT00209118 · Emory University, Other · Completed
Key facts
| NCT number | NCT00209118 |
|---|---|
| Title | Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C |
| Official title | Paroxetine for the Prevention of IFN-Alpha Associated Depression in Patients With Chronic Hepatitis C |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hepatitis C, Depression, Interferon-alpha Associated Side Effects |
| Intervention type | Drug |
| Interventions | paroxetine |
| Enrollment | 60 |
| Completion | Jul 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 11, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: